| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2020-02-13 | JANUS HENDERSON GROUP PLC | Menlo Therapeutics Inc. | 1,281,133 | 5.3% | EDGAR |
| SC 13G/A | 2020-02-04 | FIRST MANHATTAN CO | Menlo Therapeutics Inc. | 2,168,013 | 9.0% | EDGAR |
| SC 13G | 2020-01-21 | Point72 Asset Management, L.P. | Menlo Therapeutics Inc. | 1,404,265 | 5.8% | EDGAR |
| SC 13G/A | 2019-02-14 | GREAT POINT PARTNERS LLC | Menlo Therapeutics Inc. | 2,204,407 | 9.5% | EDGAR |
| SC 13G/A | 2019-02-14 | Merck & Co., Inc. | Menlo Therapeutics Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2019-02-14 | Merck Foundation, a New Jersey Nonprofit Corp | Menlo Therapeutics Inc. | 1,243,168 | 5.4% | EDGAR |
| SC 13G/A | 2019-02-13 | FMR LLC | Menlo Therapeutics Inc. | 333 | 0.0% | EDGAR |
| SC 13G/A | 2019-02-12 | JANUS HENDERSON GROUP PLC | Menlo Therapeutics Inc. | 1,617,216 | 7.0% | EDGAR |
| SC 13G | 2019-02-11 | FIRST MANHATTAN CO | Menlo Therapeutics Inc. | 1,325,375 | 5.7% | EDGAR |
| SC 13G/A | 2019-01-07 | Novo Holdings A/S | Menlo Therapeutics Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2018-08-13 | GREAT POINT PARTNERS LLC | Menlo Therapeutics Inc. | 1,556,758 | 6.8% | EDGAR |
| SC 13G | 2018-05-10 | JANUS HENDERSON GROUP PLC | Menlo Therapeutics Inc. | 2,319,698 | 10.1% | EDGAR |
| SC 13G | 2018-02-14 | Merck & Co., Inc. | Menlo Therapeutics Inc. | 1,243,168 | 5.4% | EDGAR |
| SC 13D | 2018-02-08 | venBio Global Strategic Fund II L.P. | Menlo Therapeutics Inc. | 1,461,552 | 6.4% | EDGAR |
| SC 13G | 2018-02-08 | Novo Holdings A/S | Menlo Therapeutics Inc. | 1,161,182 | 5.0% | EDGAR |
| SC 13G | 2018-02-02 | Vivo Capital VIII, LLC | Menlo Therapeutics Inc. | 4,011,236 | 17.5% | EDGAR |
| SC 13G | 2018-01-31 | FMR LLC | Menlo Therapeutics, Inc. | 1,118,054 | 5.1% | EDGAR |